Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761 ®

10.1111/cns.13095

Saved in:
Bibliographic Details
Main Authors: Kandiah, N, Ong, P.A, Yuda, T, Ng, L.-L, Mamun, K, Merchant, R.A, Chen, C, Dominguez, J, Marasigan, S, Ampil, E, Nguyen, V.T, Yusoff, S, Chan, Y.F, Yong, F.M, Krairit, O, Suthisisang, C, Senanarong, V, Ji, Y, Thukral, R, Ihl, R
Other Authors: PHARMACOLOGY
Format: Article
Published: 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/178046
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-178046
record_format dspace
spelling sg-nus-scholar.10635-1780462024-11-13T09:05:01Z Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761 ® Kandiah, N Ong, P.A Yuda, T Ng, L.-L Mamun, K Merchant, R.A Chen, C Dominguez, J Marasigan, S Ampil, E Nguyen, V.T Yusoff, S Chan, Y.F Yong, F.M Krairit, O Suthisisang, C Senanarong, V Ji, Y Thukral, R Ihl, R PHARMACOLOGY MEDICINE cholinesterase inhibitor Ginkgo biloba extract memantine n methyl dextro aspartic acid receptor blocking agent placebo add on therapy Alzheimer disease Article Asia behavior bleeding cerebrovascular disease clinical practice cognition comorbidity consensus controlled study daily life activity dementia disease association disease severity drug efficacy drug response drug safety evidence based practice human mental disease mild cognitive impairment monotherapy multiinfarct dementia practice guideline quality of life randomized controlled trial risk benefit analysis 10.1111/cns.13095 CNS Neuroscience and Therapeutics 25 2 288-298 2020-10-20T04:55:39Z 2020-10-20T04:55:39Z 2019 Article Kandiah, N, Ong, P.A, Yuda, T, Ng, L.-L, Mamun, K, Merchant, R.A, Chen, C, Dominguez, J, Marasigan, S, Ampil, E, Nguyen, V.T, Yusoff, S, Chan, Y.F, Yong, F.M, Krairit, O, Suthisisang, C, Senanarong, V, Ji, Y, Thukral, R, Ihl, R (2019). Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761 ®. CNS Neuroscience and Therapeutics 25 (2) : 288-298. ScholarBank@NUS Repository. https://doi.org/10.1111/cns.13095 17555930 https://scholarbank.nus.edu.sg/handle/10635/178046 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic cholinesterase inhibitor
Ginkgo biloba extract
memantine
n methyl dextro aspartic acid receptor blocking agent
placebo
add on therapy
Alzheimer disease
Article
Asia
behavior
bleeding
cerebrovascular disease
clinical practice
cognition
comorbidity
consensus
controlled study
daily life activity
dementia
disease association
disease severity
drug efficacy
drug response
drug safety
evidence based practice
human
mental disease
mild cognitive impairment
monotherapy
multiinfarct dementia
practice guideline
quality of life
randomized controlled trial
risk benefit analysis
spellingShingle cholinesterase inhibitor
Ginkgo biloba extract
memantine
n methyl dextro aspartic acid receptor blocking agent
placebo
add on therapy
Alzheimer disease
Article
Asia
behavior
bleeding
cerebrovascular disease
clinical practice
cognition
comorbidity
consensus
controlled study
daily life activity
dementia
disease association
disease severity
drug efficacy
drug response
drug safety
evidence based practice
human
mental disease
mild cognitive impairment
monotherapy
multiinfarct dementia
practice guideline
quality of life
randomized controlled trial
risk benefit analysis
Kandiah, N
Ong, P.A
Yuda, T
Ng, L.-L
Mamun, K
Merchant, R.A
Chen, C
Dominguez, J
Marasigan, S
Ampil, E
Nguyen, V.T
Yusoff, S
Chan, Y.F
Yong, F.M
Krairit, O
Suthisisang, C
Senanarong, V
Ji, Y
Thukral, R
Ihl, R
Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761 ®
description 10.1111/cns.13095
author2 PHARMACOLOGY
author_facet PHARMACOLOGY
Kandiah, N
Ong, P.A
Yuda, T
Ng, L.-L
Mamun, K
Merchant, R.A
Chen, C
Dominguez, J
Marasigan, S
Ampil, E
Nguyen, V.T
Yusoff, S
Chan, Y.F
Yong, F.M
Krairit, O
Suthisisang, C
Senanarong, V
Ji, Y
Thukral, R
Ihl, R
format Article
author Kandiah, N
Ong, P.A
Yuda, T
Ng, L.-L
Mamun, K
Merchant, R.A
Chen, C
Dominguez, J
Marasigan, S
Ampil, E
Nguyen, V.T
Yusoff, S
Chan, Y.F
Yong, F.M
Krairit, O
Suthisisang, C
Senanarong, V
Ji, Y
Thukral, R
Ihl, R
author_sort Kandiah, N
title Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761 ®
title_short Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761 ®
title_full Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761 ®
title_fullStr Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761 ®
title_full_unstemmed Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761 ®
title_sort treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: expert consensus on the use of ginkgo biloba extract, egb 761 ®
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/178046
_version_ 1821218121733636096